patterns of acquired resistance to egfr tkis in egfr mutation-positive nsclc
Published 7 years ago • 87 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
3:07
third generation egfr tkis for acquired resistance
-
4:26
combinations and other options for acquired resistance in egfr mutation-positive nsclc
-
3:24
options for egfr mutation-positive patients with t790m mutation-negative acquired resistance
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
24:36
treatment options for egfr t790m negative acquired resistance
-
7:48
should avastin be added to egfr tki therapy for egfr mutation-positive nsclc?
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
26:27
novel egfr inhibitors in the setting of acquired resistance
-
28:22
gracecast-088_lung-cancer_challenging cases in lung cancer: acquired resistance to egfr tki therapy
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
5:09
should a third generation egfr inhibitor be first line therapy for egfr mutation-positive nsclc?
-
14:43
gracecast-070_lung-cancer_q&a for acquired egfr tki and re-biopsying
-
2:10
slcvl raez #17 treatment options for acquired resistance to egfr tkis: t790m-negative disease
-
3:20
egfr mutated nsclc disease progression on osimertinib - 2022 program: targeted therapies forum
-
29:24
gracecast-068_lung-cancer_sequist on acquired resistance to egfr
-
3:22
what are the choices for egfr mutation-positive ar in patients w/out a t790m mutation?
-
2:00
choosing first line therapy in egfr mutations
-
3:25
are there significant differences among the 1st and 2nd generation egfr tkis?
-
17:45
individual treatments for individual egfr mutations